Navigation Links
Riverside Partners Teams with Management to Acquire IZI Medical Products
Date:4/17/2009

BOSTON, April 17 /PRNewswire/ -- Riverside Partners, based in Boston, MA, is pleased to announce that it has partnered with management to recapitalize IZI Medical Products ("IZI" or the "Company").

Founded in 1991, IZI is a provider of high quality medical markers used in Image Guided Surgery ("IGS"), radiology and radiation therapy procedures. IZI's products range from fiducial markers, used with MRI, CT, and PET technologies, to highly engineered passive reflective markers used during complex IGS procedures. The Company's medical markers are highly versatile and cross functional and can be used across a broad range of medical specialties including radiation therapy, radiology, orthopedics, and ear, nose, and throat procedures. IZI is headquartered in Baltimore, MD.

"As a family-owned business, IZI cared deeply about finding the right partner to help the Company accelerate its growth. Riverside Partners understood the nuances of our business and is already acting as a trusted partner," said Helen Zinreich Shafer, CEO of IZI Medical Products.

"Riverside is thrilled to partner with the founders of IZI," said Philip Borden, General Partner at Riverside. "IZI's focus on innovative medical markers fits perfectly with Riverside's healthcare and technology experience. We are highly enthusiastic about continuing to support IZI's strong existing management team and its multiple avenues for future growth."

About Riverside Partners

Founded in 1989, Riverside Partners is a middle market private equity firm currently investing Riverside Fund III, L.P. The fund focuses on growth-oriented companies in the healthcare and technology industries. Riverside is particularly experienced at partnering with founders, owners and management teams and it brings substantial domain expertise and operating experience to its portfolio companies. The partners at Riverside have managed more than $500 million in investments in over 50 companies. The firm is currently focused on companies with revenues between $20 - $200 million and with $5 - $25 million of EBITDA.

About IZI Medical Products

Founded in 1991, IZI Medical Products is a provider of high quality medical markers used in radiation, radiation therapy, and image guided surgery procedures. Headquartered in Baltimore, MD, IZI's products range from fiducial markers used with MRI, CT, and PET technologies to highly engineered passive reflective markers used during image guided surgery.


'/>"/>
SOURCE Riverside Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Riverside First to Offer New Treatment for Peripheral Arterial Disease
2. Riverside Partners Teams with Management to Acquire GEMCITY Engineering & Manufacturing
3. Cogdell Spencer Announces a $100 Million Development at St. Lukes Riverside Outpatient Campus In Bethlehem, Pennsylvania
4. Susan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast Cancer
5. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
6. New Medicare Equipment Bidding Program for Riverside, California Area is Rife with Errors, Says the American Association for Homecare
7. Riverside Partners Teams with Management to Acquire Innovative Product Achievements
8. Global Med Technologies(R) Signs Agreement With Californias Century Old Riverside County Regional Medical Center
9. Riverside Health System Announces $1 Million Incentive Program For Small Businesses to Offer Insurance Coverage for Employees
10. Riverside County Registered Nurses File a Lawsuit to Stop Countys Violation of Federal Law
11. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... The Aging in Motion ... established an ICD-10-CM code for sarcopenia, giving it recognition for separate reporting and data ... October 1, 2016. , Sarcopenia is defined as a combination of low muscle mass ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... affected by a health insurance co-operative bankruptcy to receive their prescription medications ... receive over 1,500 FDA-approved prescription medications from over 180 American pharmaceutical companies ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... announced its latest offering, the Protocol Calendar Exchange , is officially open ... pre-built, pre-reviewed protocol calendars available for sites to download into their clinical trial ...
(Date:4/28/2016)... Vail, Colorado (PRWEB) , ... April 28, 2016 ... ... LaPrade, MD, PhD, Chief Medical Officer at the Steadman Philippon Research Institute ... Capitol Hill Day to raise awareness about the debilitating and costly musculoskeletal ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... intelligent business communication applications and infrastructure for telecommunication service providers is pleased ... at Bestel’s Communications Network. The ACONYX Number Portability solution fully meets ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... MARLTON, N.J. , April 28, 2016   ... solutions, today announced that leading IT market research and ... Player " in the IDC MarketScape: Worldwide Pharmaceutical Track ... March 2016).  The report provides an assessment of the ... pharmaceutical track and trace software market. Logo ...
(Date:4/27/2016)... 2016  Hologic, Inc. (Nasdaq: HOLX ... the fiscal second quarter ended March 26, 2016.  ... increased 41.2%, and non-GAAP diluted EPS of $0.47 ... on a reported basis, and 6.3% on a ... another good quarter, highlighted by 14.6% growth in ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology: